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Abstract
Background: Identification of early signs of hypoxic ischemic encephalopathy (HIE) with magnetic resonance
imaging (MRI) has proven of prognostic significance. Yet, the importance of intracranial hemorrhage (ICH), being
present concomitantly had not been investigated yet, despite the known influence of hypothermia on hemostasis.
We aimed to determine whether presence of ICH on MRI alongside the signs of HIE have an impact on prognosis
in neonates with the clinical diagnosis of HIE.
Methods: A retrospective study of consecutively sampled 108 asphyxiated term infants admitted to a tertiary
neonatal intensive care unit (between 2007 and 2016), treated with whole body hypothermia and having brain MRI
within 1 week of life was conducted. Presence or absence of HIE signs on MRI (basal ganglia-thalamus, watershed
pattern and total brain injury) and on MR spectroscopy (lactate peak with decreased normal metabolites measured
by Lac/NAA ratio) and/or of the five major types of ICH were recorded. Neurodevelopmental outcome was
measured with Bayley Scales of Infant Development-II (BSID-II) test. Death or abnormal neurodevelopment (BSID-II
score < 85) was defined as poor outcome in Chi-square test. Multivariate logistic regression analysis was performed
on survivors.
Results: MRI and MR-spectroscopy (MRS) signs of HIE were present in 72% (n = 78). 36% (n = 39) of neonates had
ICH, being mainly small in size. Chi-square test showed a relationship between neurodevelopmental outcome and
initial MRI. Unadjusted logistic regression showed that neonates presenting MRI and MRS signs of HIE have 6.23
times higher odds for delayed mental development (OR = 6.2292; CI95% = [1.2642; 30.6934], p = 0.0246), than infants
without imaging alterations; with no ICH effect on outcome. Adjustment for clinical and imaging parameters did
not change the pattern of results, i.e. HIE remained an independent risk factor for delayed neurodevelopment
(OR = 6.2496; CI95% = [1.2018; 32.4983], p = 0.0294), while ICH remained to have no significant effect.
Conclusion: HIE related MRI abnormalities proved to be important prognostic factors of poor outcome in cooled
asphyxiated infants when present, suggesting that early MRI with MRS is beneficial for prognostication. Interestingly,
ICHs present in about one third of all cases had no significant effect on neurodevelopmental outcome, despite the
known hemostasis altering effects of hypothermia.
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Background
Hypoxic ischemic encephalopathy (HIE) secondary to
perinatal asphyxia is the most common cause of neo-
natal encephalopathy (NE) [1]. In term or near-term
infants (≥36 gestational weeks) with clinical signs of
moderate to severe HIE, the current standard is thera-
peutic whole body hypothermia (33.5 ± 0.2 °C core
temperature) for 72 h started within 6 h of life decreasing
mortality and morbidity [2, 3], and improving neurologic
outcome in survivors [4]. A meta-analysis of several
major randomized trials including the National Institute
of Child Health and Human Development (NICHD)
study [3] and the Total Body Hypothermia (TOBY) trial
[4] has demonstrated a reduction in death and neuro-
logical impairment at 18 months following hypothermia
[5]. The results of the Infant Cooling Evaluation Collab-
oration (ICE) trial, a multicenter, international, random-
ized controlled trial shown the reduction of the risk of
death and major sensorineural disability at 2 years of age
and concluded that whole-body hypothermia is a safe
and effective neuroprotective method with minimal ad-
verse effects [6, 7]. However hypothermia treatment also
has some consequences that the clinicians need to be
aware of during treatment. A Cochrane Collaboration
review on the safety of therapeutic hypothermia has
shown thrombocytopenia and hypotension to be the
major side effects of this therapeutic approach [8]. As
cooling may result in decreased platelet counts, it may
lead to prolongation of coagulation carrying a potentially
higher risk for intracranial hemorrhage (ICH) in HIE
newborns [9]. Besides, asphyxia very often leads to
impaired cerebral autoregulation [10] and asphyxia and
hypothermia might also cause fluctuation of cerebral
blood flow [11], being possible risk factors for intraven-
tricular hemorrhage (IVH) [12]. Performing magnetic
resonance imaging (MRI) in combination with proton
magnetic resonance spectroscopy (MRS) is a widely
accepted imaging method for quantifying the extent of
hypoxic ischemic brain injury, and predicting outcome
[13–24]. Involvement of the posterior limb of the in-
ternal capsule (PLIC) was found to be associated with
abnormal motor outcome [13, 23]. Early death and the
most severe motor impairment as cerebral palsy were
seen in association with basal ganglia injuries [23]. In a
meta-analysis including thirty-two studies and 860 in-
fants with neonatal encephalopathy deep gray matter
Lac/NAA was found to be the most accurate quantita-
tive MR biomarker for prediction of neurodevelopmental
outcome [22]. Yet, the different types of ICHs visible on
MRI in asphyxiated neonates, were not considered in
the previous studies, although they may be of additional
impact on the long term outcome of neonatal HIE, as
they may carry a potential risk of intracranial complica-
tion when hypothermic treatment is adopted [9]. The
many previous studies emphasizing the prognostic effect
of signal abnormalities on conventional sequences, diffu-
sion restriction pattern, and brain MRS either analyzed a
relatively small sample size or MRS was performed after
the first week of life or was not involved in the evalu-
ation, meaning that those HIE positive infants having
only spectroscopic abnormality were not involved in the
study population [13, 15, 25–27].
In this retrospective observational study of cooled in-
fants with the clinical diagnosis of HIE, we aimed to in-
vestigate whether the coexistence of ICH on early MRI
with the imaging signs of HIE (abnormal MRS and/or
typical patterns of diffusion restriction) have an impact
on the prognosis.
Methods
Study design and setting
This was a retrospective observational study conducted
at a university-affiliated tertiary care neonatal intensive
care unit functioning as a regional cooling center for
neonatal HIE (First Department of Pediatrics, Semmel-
weis University, Budapest, Hungary). Patients admitted
between March 2007 and March 2016 were evaluated.
Study population
Patients were selected from 210 consecutive newborn in-
fants (gestational age ≥ 36 weeks). Subjects were included
in this study if they were clinically diagnosed as moder-
ate or severe HIE, underwent therapeutic whole body
hypothermia and had at least one brain MRI within the
first 7 days of life as part of the diagnostic protocol
(Fig. 1). As the aim of our study was to investigate ICH
present during or early after hypothermia treatment and
detect diffusion and spectral changes of HIE known to
have a temporal evolution we only considered brain
MRI performed during the first week after birth.
Inclusion was based on the following diagnostic cri-
teria of the international TOBY trial (Additional file 1)
[4, 8], corresponding to moderate or severe asphyxia:
(1) at least of one of the following: continuous need for
resuscitation/ventilation at 10 min after birth, OR Apgar
score ≤ 5 at five min after birth OR arterial cord pH < 7,0
or base deficit ≥16mmol/L within 60min after birth
AND (2) altered levels of consciousness (lethargy,
stupor, coma) AND hypotonia OR abnormal reflexes or
seizures AND (3) abnormal brain background activity
registered on amplitude-integrated electroencephalog-
raphy. Exclusion criteria included: metabolic and/or gen-
etic syndromes, structural brain malformations, lack of
neurodevelopmental follow up data. Exception from the
neurodevelopmental criterion was made in case of early
death (< 28 postnatal days) OR death > 28 days associ-
ated with HIE in 9 patients who died before neurodeve-
lopmental testing hence they were considered as poor
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outcome. Altogether, 108 patients met the criteria and
were included in the analysis. There were no significant
differences in the main clinical parameters between the
included and excluded groups, see Table 1, and the Re-
sults section for details.
The primary outcome of the study was to find the pos-
sible association between ICH and/or MRI/MRS signs of
HIE and neurodevelopmental outcome based on the
Bayley Scales of Infant Development II. scale.
The Institutional Ethics Committee (Semmelweis Uni-
versity Regional and Institutional Committee of Scien-
tific and Research Ethics, SE TUKEB 62/2016) and the
Medical Research Council Ethics Committee of Hungary
(ETT TUKEB 5705–1/2016/EKU) approved this retro-
spective study.
Study interventions and exposures
Whole-body hypothermia
Whole-body hypothermia treatment was initiated as soon
as possible, using a water-filled mattress (Tecotherm©;
TecCom, Halle, Germany). The target rectal temperature
was between 33 and 34 °C, maintained for 72 h. In the
rewarming phase, temperature increase velocity was
0.5 °C/h. All infants were ventilated throughout the cool-
ing and rewarming phase. Knowing that severe hyperoxae-
mia and severe hypocapnia are associated with adverse
outcome in infants with post-asphyxial HIE [28–30] closer
monitoring and individualized oxygen supplementation
and ventilation was maintained. Initial parameters of
mechanical ventilation were set according to the local
protocol: synchronized intermittent mandatory ventilation
with volume guarantee (target tidal volume 5ml/kg, re-
spiratory rate and end expiratory pressure set as needed).
Taking into consideration of the fact that asphyxiated
infants may need lower ventilator settings to maintain
normocarbia, our protocol was designed to maintain a
pCO2 of 40 to 60mmHg consistently. Therefore, during
the first hours of life, oxygen supplementation and ventila-
tion were rigorously controlled with blood gases routinely
taken every 30 to 60 mins, until a steady state was
reached, then every 6 h afterwards during the whole extent
of hypothermia treatment. This protocol ensured timely
adjustment of ventilation parameters to evade sustained
excursion from optimal blood gas values.
4 w/ brain malformations, metabolic 
diseases and genetic syndromes
35 w/o brain MRI in first week of life
63 w/o follow-up
9 died, considered poor outcome



























Fig. 1 Patient enrollment. Based on the inclusion and exclusion criteria 108 neonates were selected in the study from the initial 210 patients
Table 1 Perinatal characteristics of HIE newborns enrolled and excluded from the study. GA: gestational age, BE: base excess
Variable Included (n = 108) Excluded (n = 102) p value
Age at MRI (h) mean ± SD; (range) 65.12 ± 46.34 (4.42–165.67) – –
GA (wks) mean ± SD; (range) 38.5 ± 1.51 (36–43) 39.05 ± 1,56 (36–43) 0.1293
Birth weight (g) mean ± SD; (range) 3099.52 ± 447.89 (1490–4300) 3196.78 ± 497.94 0.7357
1-min Apgar score median (range) 2 (0–8) 2 (0–8) 0.4560
5-min Apgar score median (range) 4 (0–9) 5 (0–9) 0.2226
10-min Apgar score median (range) 6 (0–9) 6 (0–9) 0.0698
pH mean ± SD (range) 7.04 ± 0.18 (6.3–7.38) 7.01 ± 0.21 (6.34–7.6) 0.2217
BE (mEq/l) mean ± SD (range) −16.57 ± 5.94 (− 28–1) − 16.04 ± 6.55 (− 29–1.7) 0.4985
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Continuous morphine (Morphine hydrochloride 10
mg/mL; TEVA Magyarország Zrt., Gödöllő, Hungary)
sedation (10 μg/kg BW/h) was started following the
loading dose (0.1 mg/kg BW) administered when the
cooling was initiated. Phenobarbitone (Gardenal 40 mg;
Aventis, Maisons-Alfort, France, 20 mg/kg BW) was
given as the first line of anticonvulsant therapy if clinical
or electrophysiological seizures were detected. In case of
non-controlled seizures, the phenobarbitone loading
dose was repeated, or midazolam (Midazolam Torrex 5
mg/ml; Chiesi Pharmaceuticals GmbH, Vienna, Austria)
was given in single or repeated doses (0.1 mg/kg BW) or
in continuous infusion (0.1 mg/kg BW/h). In some cases,
newborns received lidocaine, phenytoin, diazepam or
chloral hydrate alternatively, according to the attending
clinician’s decision.
MR imaging
All MRIs were acquired in the first 7 days of life on a
Philips Achieva or Ingenia 3 T scanner (Philips Medical
Systems, Best, The Netherlands), with 8-channel SENSE
head-coils, at the former MR Research Center of Semmel-
weis University.1 Brain MRI included the following se-
quences: T1-weighted 3D spoiled gradient echo [TR =
10.88ms, TE = 5.258ms, slice thickness = 1mm, gap =1
mm], axial and coronal T2-weighted turbo spin echo [TR =
4000ms (axial), 2766ms (coronal), TE = 100ms, slice
thickness = 3mm, gap = 4mm], axial T2*-weighted gradi-
ent echo [TR = 561.5ms, TE = 16.11ms, slice thickness = 3
mm, gap = 4mm] OR axial SWI (susceptibility weighted
imaging) [TR = 31ms, TE = 7.2ms, slice thickness = 2mm,
gap-1 =mm (interleaved slices)] and diffusion-weighted
images [b-value = 1000s/mm2] with ADC maps, and
single-voxel proton MR spectroscopy with PRESS (Point
Resolved Spectroscopy) acquisition [TE = 35 and/or 144
and/or 288ms] obtained from the left thalamus – basal
ganglia. Average imaging time was 30min. A neonatologist
was present throughout the procedure. For the time of the
examination, the infants were removed from the incubator
and received continuous morphine sedation. Heart rate
and oxygen saturation were monitored using a Medrad®
Veris® MR monitoring system. In case of intubated infants,
skilled personnel provided manual ventilation with an
AMBU bag throughout the MRI examination.
Neurodevelopmental follow-up
Neurodevelopmental outcome was measured by Bayley
Scales of Infant Development II tool-kit (BSID-II), per-
formed between 18 and 26 months of age by trained
personnel, blinded to the MRI results. Although BSID-II
was updated to a 3rd edition during the follow-up period
of our study, it was not translated and standardized until
2018, therefore BSID-II test was performed in all our
patients. BSID-II comprises two scales including the
Mental Developmental Index (MDI) and Psychomotor
Developmental Index (PDI). The MDI provides an
assessment of memory, problem solving, sensory percep-
tion, hand-eye coordination, imitation and early lan-
guage. The PDI measures gross and fine motor skills
[31, 32]. The normal range of PDI and MDI is between
85 and 114, a score lower than 85 suggests mildly de-
layed development, and a score below 70 represents sig-
nificantly delayed development. A score greater than or
equal to 115 stands for accelerated performance. For the
Chi-square test we defined poor outcome as either early
death OR mildly to significantly delayed performance
(MDI or PDI < 85). All other outcomes were considered
as good outcome. A neurodevelopmental outcome score
was non-applicable (N/A) when obtaining a reliable
measurement was not achievable. Logistic regression
analysis was based on individual scores (see below).
Data analyses
Data recording and extraction were made using our novel
in-house built asphyxia registry database, iSORT (Intelli-
gent structured online reporting tool, Bioscreen Ltd. Deb-
recen, Hungary) [33]. Trained pediatric radiologist blinded
to the clinical history and neurodevelopmental results
retrospectively evaluated the imaging signs of HIE and the
presence and type of hemorrhage. HIE related abnormality
was reported, when a lactate peak and relatively low values
of normal metabolites (represented by Lac/NAA height ra-
tios measured on MRS with TE = 144ms) were present on
MR-spectroscopy [34, 35] AND/OR HIE related diffusion
restriction or signal abnormalities on T1- and T2 weighted
images were present [36–38]. Predominantly basal-ganglia-
thalamus pattern was reported when central grey matter
nuclei and perirolandic cortex involvement was seen bilat-
erally with or without associated hippocampal and brain
stem involvement and the absence of a normal high-signal
intensity of the posterior limb of the internal capsule [37].
Watershed predominant pattern injury was diagnosed
when the vascular watershed zones (anterior-middle cere-
bral artery and posterior-middle cerebral artery) were
involved uni- or bilaterally affecting the white matter or in
severe cases the overlying cortex as well [37]. In total brain
injury widespread involvement of the subcortical white
matter and cortex was seen with relative sparing of the im-
mediate periventricular white matter and central grey mat-
ter [36]. The predominant (basal ganglia/watershed/total
brain injury) patterns of HIE were primarily identified on
the DWI and ADC maps on early MRI. As abnormalities
observed with diffusion imaging depend on the delay
between birth and MRI showing pseudonormalization
1The MR Research Center has been reorganized and renamed to
Department of Neuroradiology, Medical Imaging Centre, Semmelweis
University on August 29, 2019.
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around the 6th and 7th day after the insult, conventional
T1- and T2 weighted sequences were also evaluated. MRI
was considered normal in the absence of all the above
listed findings. Neonatal intracranial hemorrhage (ICH)
was assessed on T2*GRE, SWI and T1-weighted images.
The following five subtypes of ICH were distinguished:
subdural hemorrhage (SDH), subarachnoid hemorrhage
(SAH), germinal matrix hemorrhage (GMH), intraventricu-
lar hemorrhage (IVH) and parenchymal hemorrhage (P)
[39]. The location, size and the presence/absence of mass-
effect were assessed.
Descriptive statistical analysis was carried out; con-
tinuous measurements were presented as mean ± SD
(min-max) while categorical measurements were pre-
sented in numbers and percentages. Parameters of the
included and excluded cohorts were compared with
Mann-Whitney U test, as some of the data was ordinal
(e.g. Apgar, pH, etc.). Patients were categorized into four
groups based on the presence or absence of ICH and
HIE on MRI. BSID-II scores were registered for every
patient, detailed above. Chi-square test was performed
to assess whether the observed distributions of PDI and
MDI and the MRI signs of HIE and ICH are independ-
ent regarding the outcome (null hypothesis) or if there is
proof for a relationship between late neurodevelopmen-
tal outcome and initial MRI findings (alternative hypoth-
esis). We performed multivariate logistic regression
analysis (in Matlab 9.2, The MathWorks Inc. Natick,
MA) on survivors to detect possible relationships be-
tween poor outcome (BSID-II score < 85) and/or ICH
and/or HIE signs on MRI including other covariates as
clinical predictors of interest: 5 min Apgar score, base-
line pH and age at MRI. One could argue for the inclu-
sion of base excess and/or temperature, however the
latter two should not affect the association as they are
mostly collinear with other already included parameters,
hence they were omitted. The results are provided in
terms of odds ratios, and confidence intervals.
Results
Clinical characteristics of 108 neonates with moderate-
to-severe HIE meeting the eligibility criteria and 102 pa-
tients excluded from the study are presented in Table 1.
Clinical parameters of the included and excluded group
of patients showed no significant difference.
The average age at which brain MRI scans were ob-
tained was 65.12 ± 46.34 h. All brain MRIs were per-
formed after passive cooling started during transport or
after the initiation of therapeutic hypothermia. Of these
108 patients 9 patients died in the perinatal period
(6.67%). None of our patients died between 28 days and
the neurodevelopmental follow-up examination. Twelve
children had significantly delayed development (MDI
and/or PDI < 70). Seven of these patients were diagnosed
with cerebral palsy. Twenty-seven children received an
MDI and/or PDI score compatible with mildly delayed
development (70–84).
The 108 subjects were divided into four groups based on
the presence (+) or absence (-) of the MRI signs of ICH
(Fig. 2) and HIE (Figs. 3 and 4): Group1: Infants presenting
Fig. 2 Observed types of ICH. MR images show two sets of examples for intracranial hemorrhages of different types, locations and sizes observed
in asphyxiated infants. SDH: subdural hemorrhage, SAH: subarachnoid hemorrhage, GMH: germinal matrix hemorrhage, IVH: intraventricular
hemorrhage, hPVL: hemorrhagic periventricular leukomalacia
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neither the signs of HIE nor ICH (Additional file 2).
Group2: Patients without the imaging signs of HIE show-
ing ICH (Additional file 3). Group3: Both HIE and ICH is
visible (Additional file 4). Group4: Only HIE signs are
present (Additional file 5). Neurodevelopmental outcome
results were registered for each patient.
Group1: HIE−/ICH- cases
Fifteen infants showed no MRI or MRS signs of HIE (al-
though they received cooling based on clinical criteria of
moderate to severe HIE) and no ICH. The majority of
these patients (80%, n = 12) showed normal neurodeve-
lopmental outcome.
Group2: HIE−/ICH+ cases
Altogether 15 hypothermia treated patients had isolated
ICH without the MRI signs of HIE. Eight patients had
only one type of extra-axial or parenchymal hemorrhage.
The other seven patients had intracranial hemorrhages
of multiple types and localizations. The most common
ICH types were SDH (n = 9) and SAH (n = 9), which
were small without any mass-effect and caused most
probably by traumatic delivery. The extra-axial hemor-
rhages predominantly occurred in the posterior cranial
fossa, along the tentorium cerebelli. IVH was present in
three patients, parenchymal hemorrhage in two infants
and GMH in one neonate. All fifteen patients with
hemorrhage but without the MRI signs of HIE achieved
a normal PDI score (≥85) on neurodevelopmental test-
ing. The MDI scores were abnormal in two patients; one
of whom had IVH and SAH with multiple foci of GMH
besides space occupying cerebral and cerebellar paren-
chymal hemorrhages leading to hydrocephalus.
Group3: HIE+/ICH+ cases
Twenty-four patients showed MRI signs of HIE as well
as ICH. There were 10 neonates (41%) who only had
abnormal MRS (without restricted diffusion and T1-,
T2- signal abnormality). Four patients (17%) were af-
fected by global severe HIE, four neonates (17%) showed
watershed pattern, and another four (17%) presented
with basal ganglia-thalamus pattern of injury. In two pa-
tients (8%) the signs of hemorrhagic PVL were seen. All
but one patient (#3.3) had small ICHs, mainly petechial
parenchymal hemorrhages in the periventricular white
matter (n = 10) or non-complicated SAH (n = 8), IVH
(n = 9) and SDH (n = 7) supposed to be traumatic in ori-
gin. Low MDI and/or PDI scores in keeping with an ad-
verse outcome were present in 50% (n = 12) of this
patient group.
Group4: HIE+/ICH- cases
Altogether 54 patients composed the group of HIE signs
on MRI without intracranial hemorrhage. Isolated 1H-
MR-spectroscopy abnormality (without restricted diffu-
sion and T1-, T2- signal abnormality) was present in 19
patients (35%). Eight patients (15%) were affected by
global severe HIE, seven neonates (13%) showed water-
shed pattern, and eighteen infants (33%) presented with
basal ganglia-thalamus pattern of injury. In two patients
(4%) the prominent deep medullary veins were suggest-
ive for HIE. Low MDI and/or PDI scores in keeping with
an adverse outcome were present in 61% (n = 33) of this
patient group.
Fig. 3 Patterns of HIE. Watershed (peripheral) type of injury, diffusion
restriction bilaterally; Basal ganglia – thalamus (central) pattern,
restricted diffusion in bilateral thalami and putamina; Global
diffusion restriction on DWI and ADC
Fig. 4 MRS pattern in HIE. Point-Resolved Spectroscopy (PRESS)
acquired from the left thalamus (TE = 144ms) on the 2nd day of life
of a term infant shows prominent lactate peak, a characteristic
inverse doublet, resonating at 1.3 ppm and decreased N-acetyl-
aspartate (NAA), creatine (Cr) and choline (Cho)
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Examples for the observed types of ICH, the main pat-
terns and the typical spectral abnormalities in HIE are
presented on Figs. 2, 3 and 4.
Chi-square test and logistic regression analysis
Data on neurodevelopmental outcome and MRI results
of the four groups were summarized in two by four con-
tingency tables (Table 2). Approximately 36% (n = 39) of
the examined patient population had axial or extra-axial
bleeds, mainly parenchymal or subdural hemorrhages.
HIE was present in 62% (n = 24) of such patients (all
with intracranial hemorrhage), while in the other 38%
(n = 15) of the infants with ICH the imaging signs of
HIE were completely absent. MRI evidence of HIE was
absent in 28% (n = 30) of the neonates who were treated
with hypothermia. Chi-square test demonstrated signifi-
cant relationship between ICH and HIE and the out-
come measured by PDI (χ2 = 13.025, df = 3, p = 0.0046)
and MDI (χ2 = 14.2673, df = 3, p = 0.0026).
After finding a statistically significant relationship be-
tween late neurodevelopmental outcome and HIE and
ICH on initial MRI, further analysis using logistic regres-
sion was performed in patients whose PDI (n = 99) and
MDI (n = 98) scores were available (9 infants died early
on, one had N/A MDI score). Distribution of neurodeve-
lopmental scores in the four patient groups are pre-
sented on bean plots (Fig. 5).
Multivariate logistic regression was used to evaluate
the effect of HIE and/or ICH on neurodevelopmental
outcome, measured by MDI and PDI scores, adjusting
for other clinically relevant parameters including age at
MRI, 5 min Apgar score and pH. Table 3. demonstrates
the adjusted and unadjusted odds ratios for each vari-
able. Regarding MDI, the unadjusted logistic regression
analysis (χ2 = 11.1, df = 94, p = 0.011) showed that the
presence of MRI signs of HIE had significant negative ef-
fect on the outcome (OR = 6.2292; 95%CI [1.2642;
30.6934]; p = 0.0246), meaning neonates who exhibited
imaging signs of HIE had six times higher odds of an ab-
normal MDI score, than those without imaging signs of
HIE or ICH. In the same model, neither ICH, nor the
simultaneous presence of ICH and HIE had significant
modulatory effect (p > 0.9999 and p = 0.7121, respect-
ively). Regarding PDI, the logistic regression analysis
(χ2 = 14.4, df = 95, p = 0.002) showed that none of the
conditions (signs of HIE, ICH, or both) proved to have
significant modulatory effect on psychomotor develop-
ment (p = 0.2014, p > 0.9999, and p > 0.9999, respect-
ively). After adjusting for confounds, HIE remained an
independent risk factor for delayed neurodevelopment
with respect to MDI (logistic regression model: χ2 =
16.000, df = 88, p = 0.014, effect of HIE: OR = 6.2496;
CI95% = [1.2018; 32.4983], p = 0.0294), while ICH
remained to have no significant effect. Similarly, regard-
ing PDI the adjusted logistic regression model (χ2 = 16.9,
df = 88, p = 0.010) revealed no modulatory effect of the
presence of HIE, ICH, or both (p = 0.1997, p > 0.9999,
and p > 0.9999, respectively). Neither the 5 min Apgar
score, nor the pH, nor the time of MRI exam proved to
be significant covariates for MDI (p = 0.1158, p = 0.3415,
and p = 0.4105, respectively) or PDI (p = 0.1675, p =
0.8622, and p = 0.5268, respectively).
Discussion
Here, we assessed the rate of ICH in a cohort of patients
with clinical signs of HIE, and also considered the effect
of ICH on the long term outcome in this patient popula-
tion. Several studies demonstrate the benefits and
compare the accuracy of MRI in identifying HIE and
predicting the long term neurodevelopmental outcome
[1, 36, 40–42], nevertheless, to our knowledge this was
the first study considering the possible relevance of ICH
accompanying HIE. Three major randomized controlled
trials as the NICHD study [3], the TOBY trial [4] and
the ICE trial [6, 7] have demonstrated a reduction in
death and neurological impairment after hypothermia
treatment. The above trials also included brain MRI, but
compared to our study these were relatively late exami-
nations performed after the first week of life in average,
assessing the patterns of injury classified by Rutherford
mainly on conventional T1- and T2-weighted sequences,
and partially on diffusion weighted imaging. The average
age on completion of MRI in our study was around the
third day of life. The pattern of the injury defined as pre-
dominantly basal ganglia or thalamic lesions, watershed
predominant injury or global brain insult were classified
on diffusion weighted images in most of the cases. MR-
spectroscopy was also considered, revealing 29 patients
with spectra compatible with HIE and without other im-
aging signs of hypoxic-ischemic injury.
Published incidence of asymptomatic ICH after vaginal
delivery of full-term neonates is approximately 25%, [43]
Table 2 Two by four contingency table summarizing results of
MRI and MDI, PDI
HIE−/ICH- HIE−/ICH+ HIE+/ICH- HIE+/ICH+ Total
No. of pts. No. of pts. No. of pts. No. of pts.
MDI normal 13 13 24 13 63
abnormal 2 2 30 10 44
total 15 15 54 23a 107
PDI normal 12 15 29 14 70
abnormal 3 0 25 10 38
total 15 15 54 24 108
Normal MDI ≥85, abnormal MDI < 85. a MDI was N/A in 1 patient. Lowest
expected value = 6.111; χ2 = 14.2673; df = 3; p = 0.0026. Normal PDI ≥85,
abnormal PDI < 85. Lowest expected value = 5.278; χ2 = 13.025; df = 3; p =
0.0046. (HIE: hypoxic ischemic encephalopathy, ICH: intracranial hemorrhage,
MDI: Mental Developmental Index, PDI: Psychomotor Developmental Index)
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yet symptomatic ICH is much less common, accounting
for 4 per 10,000 live births [44]. The rate of ICH in our
patient population of cooled asphyxiated infants was
higher (36%) than found in literature. The majority of
ICHs in our study were small extra-axial or petechial
parenchymal hemorrhages localized in the posterior fossa,
but there also were multifocal hemorrhages with various
patterns of bleeding. The origin of the observed hemor-
rhages may be related to delivery [45] or to the cooling itself
[11, 12], and while the cooling-induced thrombocytopenia
[6] may potentially lead to a progression of these bleedings,
we have no evidence of progression in our data, partly due
to a lack of follow-up imaging. Nevertheless, progression
seems to be unlikely given the fact that these ICHs proved
to have no significant modulatory effect on the long term
mental (MDI) and psychomotor (PDI) developmental
outcome.
Early MRI evidence of HIE proved to be a significant
predictor of an adverse outcome eventuating more than
six times higher odds for abnormal mental development
in an asphyxiated child compared to a neonate without


















HIE-/ICH- HIE-/ICH+ HIE+/ICH- HIE+/ICH+
Fig. 5 Distribution of neurodevelopmental outcome scores. Bean plots showing the distribution of neurodevelopmental outcome scores (MDI
and PDI) in the 4 patient groups. Wide black lines represent the medians, the dotted line at 85 represents the threshold between good and
poor outcome
Table 3 Logistic regression predicting the likelihood of adverse outcome
MDI unadjusted MDI adjusted
(model fit: χ2 = 11.1, df = 94, p = 0.011*) (model fit: χ2 = 16.000, df = 88, p = 0.014*)
OR (95% CI) p aOR (95% CI) p
ICH NA NA 0.9999 1.2408 (0.1445–10.6554) 0.8441
HIE 6.2292 (1.2642–30.6934) 0.0246* 6.2496 (1.2018–32.4983) 0.0294*
Time of MRI (h) 0.9954 (0.9847–1.0063) 0.4105
5 min Apgar 0.8259 (0.6507–1.0482) 0.1158
pH 0.3014 (0.0255–3.5682) 0.3415
ICH×HIE 0.6421 (0.0611–6.7517) 0.7121 0.5939 (0.0540–6.5381) 0.6703
PDI unadjusted PDI adjusted
(model fit: χ2 = 14.4, df = 95, p = 0.002*) (model fit: χ2 = 16.9, df = 88, p = 0.010*)
OR (95% CI) p aOR (95% CI) p
ICH NA NA 0.9999 NA NA 0.9999
HIE 2.4828 (0.6152–10.0198) 0.2014 2.5692 (0.6074–10.8666) 0.1997
Time of MRI (h) 0.9963 (0.9851–1.0077) 0.5268
5 min Apgar 0.8443 (0.6639–1.0737) 0.1675
pH 0.8019 (0.0663–9.7067) 0.8622
ICH×HIE NA NA 0.9999 NA NA 0.9999
OR: odds ratio, aOR: adjusted odds ratio, CI confidence interval. Logistic regression model predicting likelihood of adverse outcome on the Bayley Scales of Infant
Development II Test, based on the presence of MRI signs of HIE and ICH on early MRI, the time of the MRI examination, the 5 min Apgar score, and the initial pH;
asterisks denote significance at level p < 0.05
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of ICH. Vice versa, in almost all of the cases clinically
categorized as HIE (n = 30) but lacking MRI evidence of
HIE the neurodevelopmental outcome was within nor-
mal limits. This is in line with the converging evidence
showing the negative outcome associated with the pres-
ence of HIE signs on MRI imaging performed after the
first week of life [3, 4, 6, 7], and also consistent with the
literature regarding early MRI [34].
There are some aspects of the study that can be consid-
ered as limitations, the first is the retrospective nature of
the data presented. A prospective trial could allow for bet-
ter controlled patient selection, and could also lead to
more consistent data acquisition, nevertheless clinical data
obtained in a general setting is equally important [35].
While our data derived from 210 consecutive patients
gives a cross sectional overview of the patient population
we observed in a 9-year period, it has its own inconsisten-
cies regarding imaging and follow-up, eventually leading
to a relatively high rate of exclusion. This may be consid-
ered a limitation of our study, nevertheless the lack of sig-
nificant differences in the basic clinical parameters (e.g.
Apgar scores, pH, etc.) between the included and excluded
patient cohorts suggests that our sampling is representa-
tive of the population categorized as HIE patients based
on clinical grounds, i.e. the TOBY criteria [4].
It is important to note, that we excluded those patients
whose first MRI was performed after the first week of life,
given the main body of HIE-related literature [34, 38, 40]
this can be considered as a shortcoming, however our goal
was to investigate the early and transient signs of HIE on
MRI alongside with the presence of ICH. The fact that
our findings on the outcome-modifying effects of HIE
signs present on MRI are in line with the literature ob-
tained on later acquired imaging data [3, 4, 6, 7] justifies
the appropriateness of our selection criteria.
The relatively wide age range at follow-up developmen-
tal testing can also be considered as a potential limitation,
however the BSID-II is standardized to be used between 1
and 42months of age, and the patient’s age is properly
taken into consideration for the final scores [32, 46]. Fur-
thermore, one may also consider the use of BSID-II in-
stead of BSID-III a limitation, please note however that
the BSID-III was not translated and standardized to Hun-
garian until 2018; till then the BSID-II was the standard
developmental test battery available in Hungarian.
The lack of an objective scaling system to image the se-
verity of HIE may also be considered as limitation. Al-
though, there are several scoring systems available, most of
the scales depend on late MRI and conventional images,
some of them on the early diffusion pattern alone, yet there
is no score including MR spectroscopy in the grading,
which could be used in our evaluation [27, 37, 47–49]. The
reason for the lack of published MRS grading is that there
is very narrow time window for the initiation of the
hypothermia (maximum of 6 h from birth) [50, 51], which
limits the opportunity of performing an early MRI and
there are still many centers where MR-spectroscopy is not
included in the imaging protocol [52, 53]. The recent rec-
ommendation of the American College of Obstetricians
and Gynecologists outlines the importance of early MRI
(first 24–96 h of life) for likely timing of the hypoxic-
ischemic insult and further follow-up imaging (7–21 days
of life) to define the full nature of the abnormalities [54],
but does not define or suggest a protocol for brain MRI in
an asphyxiated infant.
Finally, one can consider the fact that MR examina-
tions in our study were performed after passive cooling
during transport or under or after hypothermic treat-
ment as a limitation of our study, however we do not
consider this a clinically relevant limitation as there is
published evidence that the predictive value of MRI for
subsequent neurological impairment is not affected by
previous hypothermia [55]. In fact, MRI is accurate for
evaluating the presence and extent of hypoxic brain in-
jury under and after hypothermia [56].
To successfully overcome the above-mentioned limita-
tions more studies on early MRI need to be performed
involving more subjects and gathering more imaging
data to gain better insight whether there is any interfer-
ence between hypothermic treatment and imaging that
may render the MRI results of asphyxiated infants
unremarkable.
Conclusions
This study attempted to determine the predictive value
of intracranial hemorrhage in association with HIE re-
lated MR imaging signs in comparison with neurodeve-
lopmental results in cooled asphyxiated infants.
Intracranial hemorrhage took a remarkable share affect-
ing approximately one-third of infants treated with
hypothermia. Intracranial hemorrhagic complications
which were present before or evolve during treatment
showed no significant influence on outcome despite the
known negative hematological (platelet dysfunction,
thrombocytopenia) effects of cooling. Having more than
six time higher odds for abnormal neurodevelopmental
outcome the presence of HIE related MR-spectroscopy
abnormalities and diffusion restriction proved to have
important prognostic value. Therefore, the implementa-
tion of early MRI in the diagnostic algorithm needs to
be considered.
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